These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38203308)

  • 1. Development of A Radiomic Model for
    Doniselli FM; Pascuzzo R; Agrò M; Aquino D; Anghileri E; Farinotti M; Pollo B; Paterra R; Cuccarini V; Moscatelli M; DiMeco F; Sconfienza LM
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning-based radiomic, clinical and semantic feature analysis for predicting overall survival and MGMT promoter methylation status in patients with glioblastoma.
    Lu Y; Patel M; Natarajan K; Ughratdar I; Sanghera P; Jena R; Watts C; Sawlani V
    Magn Reson Imaging; 2020 Dec; 74():161-170. PubMed ID: 32980505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiregional radiomics features from multiparametric MRI for prediction of MGMT methylation status in glioblastoma multiforme: A multicentre study.
    Li ZC; Bai H; Sun Q; Li Q; Liu L; Zou Y; Chen Y; Liang C; Zheng H
    Eur Radiol; 2018 Sep; 28(9):3640-3650. PubMed ID: 29564594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics signature: A potential biomarker for the prediction of MGMT promoter methylation in glioblastoma.
    Xi YB; Guo F; Xu ZL; Li C; Wei W; Tian P; Liu TT; Liu L; Chen G; Ye J; Cheng G; Cui LB; Zhang HJ; Qin W; Yin H
    J Magn Reson Imaging; 2018 May; 47(5):1380-1387. PubMed ID: 28926163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomics for predicting MGMT status in cerebral glioblastoma: comparison of different MRI sequences.
    Zheng F; Zhang L; Chen H; Zang Y; Chen X; Li Y
    J Radiat Res; 2024 May; 65(3):350-359. PubMed ID: 38650477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive O
    Hajianfar G; Shiri I; Maleki H; Oveisi N; Haghparast A; Abdollahi H; Oveisi M
    World Neurosurg; 2019 Dec; 132():e140-e161. PubMed ID: 31505292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting MGMT Promoter Methylation of Glioblastoma from Dynamic Susceptibility Contrast Perfusion: A Radiomic Approach.
    Crisi G; Filice S
    J Neuroimaging; 2020 Jul; 30(4):458-462. PubMed ID: 32374045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multi-sequence and habitat-based MRI radiomics signature for preoperative prediction of MGMT promoter methylation in astrocytomas with prognostic implication.
    Wei J; Yang G; Hao X; Gu D; Tan Y; Wang X; Dong D; Zhang S; Wang L; Zhang H; Tian J
    Eur Radiol; 2019 Feb; 29(2):877-888. PubMed ID: 30039219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusion Radiomics Features from Conventional MRI Predict MGMT Promoter Methylation Status in Lower Grade Gliomas.
    Jiang C; Kong Z; Liu S; Feng S; Zhang Y; Zhu R; Chen W; Wang Y; Lyu Y; You H; Zhao D; Wang R; Wang Y; Ma W; Feng F
    Eur J Radiol; 2019 Dec; 121():108714. PubMed ID: 31704598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving MGMT methylation status prediction of glioblastoma through optimizing radiomics features using genetic algorithm-based machine learning approach.
    Do DT; Yang MR; Lam LHT; Le NQK; Wu YW
    Sci Rep; 2022 Aug; 12(1):13412. PubMed ID: 35927323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of MGMT Status for Glioblastoma Patients Using Radiomics Feature Extraction From
    Qian J; Herman MG; Brinkmann DH; Laack NN; Kemp BJ; Hunt CH; Lowe V; Pafundi DH
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1339-1346. PubMed ID: 32634544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: a region of interest based analysis.
    Han Y; Yan LF; Wang XB; Sun YZ; Zhang X; Liu ZC; Nan HY; Hu YC; Yang Y; Zhang J; Yu Y; Sun Q; Tian Q; Hu B; Xiao G; Wang W; Cui GB
    BMC Cancer; 2018 Feb; 18(1):215. PubMed ID: 29467012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative prediction of MGMT promoter methylation in glioblastoma based on multiregional and multi-sequence MRI radiomics analysis.
    Li L; Xiao F; Wang S; Kuang S; Li Z; Zhong Y; Xu D; Cai Y; Li S; Chen J; Liu Y; Li J; Li H; Xu H
    Sci Rep; 2024 Jul; 14(1):16031. PubMed ID: 38992201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiogenomic classification for MGMT promoter methylation status using multi-omics fused feature space for least invasive diagnosis through mpMRI scans.
    Qureshi SA; Hussain L; Ibrar U; Alabdulkreem E; Nour MK; Alqahtani MS; Nafie FM; Mohamed A; Mohammed GP; Duong TQ
    Sci Rep; 2023 Feb; 13(1):3291. PubMed ID: 36841898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State of Radiomics in Glioblastoma.
    Taha B; Boley D; Sun J; Chen CC
    Neurosurgery; 2021 Jul; 89(2):177-184. PubMed ID: 33913492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas.
    Korfiatis P; Kline TL; Coufalova L; Lachance DH; Parney IF; Carter RE; Buckner JC; Erickson BJ
    Med Phys; 2016 Jun; 43(6):2835-2844. PubMed ID: 27277032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive Assessment of O(6)-Methylguanine-DNA Methyltransferase Promoter Methylation Status in World Health Organization Grade II-IV Glioma Using Histogram Analysis of Inflow-Based Vascular-Space-Occupancy Combined with Structural Magnetic Resonance Imaging.
    He W; Li X; Hua J; Liao S; Guo L; Xiao X; Liu X; Zhou J; Wang W; Xu Y; Wu Y
    J Magn Reson Imaging; 2021 Jul; 54(1):227-236. PubMed ID: 33590929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Learning MRI-based classification models for MGMT methylation status prediction in glioblastoma.
    Kanas VG; Zacharaki EI; Thomas GA; Zinn PO; Megalooikonomou V; Colen RR
    Comput Methods Programs Biomed; 2017 Mar; 140():249-257. PubMed ID: 28254081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminating MGMT promoter methylation status in patients with glioblastoma employing amide proton transfer-weighted MRI metrics.
    Jiang S; Rui Q; Wang Y; Heo HY; Zou T; Yu H; Zhang Y; Wang X; Du Y; Wen X; Chen F; Wang J; Eberhart CG; Zhou J; Wen Z
    Eur Radiol; 2018 May; 28(5):2115-2123. PubMed ID: 29234914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of peritumoral hyperintensity on pre-operative T2-weighted MR images in glioblastoma: Additive prognostic value of Minkowski functionals.
    Choi Y; Ahn KJ; Nam Y; Jang J; Shin NY; Choi HS; Jung SL; Kim BS
    PLoS One; 2019; 14(5):e0217785. PubMed ID: 31150499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.